Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (2.845)

1

Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Harvey-Jones, E. | Raghunandan, M. | Robbez-Masson, L. | +36

2

PARP1 expression predicts PARP inhibitor sensitivity and correlates with metastatic potential and overall survival in melanoma

enthalten in: International journal of cancer | 2024

von Fröhlich, L. | Villar-Miyar, A. | Heintze, T. | +2

3

Inactivation of VRK1 Sensitizes Ovarian Cancer to PARP Inhibition through regulating DNA-PK stability

enthalten in: Experimental cell research | 2024

von Kim, D. | Yun, H. | You, J. | +5

4

Spatiotemporal Concurrent PARP Inhibitor Sensitization based on Radiation-Responsive Nanovesicles for Lung Cancer Chemoradiotherapy

enthalten in: Advanced healthcare materials | 2024

von Kang, F. | Niu, M. | Zhou, Z. | +5

5

DePARylation is critical for S phase progression and cell survival

enthalten in: eLife | 2024

von Nie, L. | Wang, C. | Huang, M. | +10

UpdateOf: bioRxiv. 2024 Feb 02;:. - PMID 37577639

6

Impact of Drp1-regulated changes in T cell activity on the combined antitumor effects of PARPi and PD-1 inhibitors

enthalten in: International immunopharmacology | 2024

von Ma, J. | Song, J. | Yi, X. | +5

7

PARP Inhibitors in the Treatment of Prostate Cancer : From Scientific Rationale to Clinical Development

enthalten in: The world journal of men's health | 2024

von Kwon, W.

8

Real-world data of poly (ADP-ribose) polymerase inhibitor response in Japanese patients with ovarian cancer

enthalten in: Cancer medicine | 2024

von Uekusa, R. | Yokoi, A. | Watanabe, E. | +9

9

Current post-surgical treatment strategies in first-line ovarian cancer

enthalten in: Bulletin du cancer | 2024

von Ouali, K. | Michels, J. | Blanc-Durand, F. | +9

10

Successful Management of Ovarian Cancer Progressing on Olaparib by Niraparib Following Cytoreduction : A Case Report

enthalten in: In vivo (Athens, Greece) | 2024

von Endo, Y. | Kamo, N. | Kato, A. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[285]